Gunilla Örn

Title: Gunilla Örn: Innovator in Pharmaceutical Compositions

Introduction

Gunilla Örn is a notable inventor based in Turku, Finland. She has made significant contributions to the field of pharmaceuticals, particularly in the development of soluble compositions for antiestrogens. Her work has implications for various therapeutic applications.

Latest Patents

Gunilla Örn holds a patent for "Soluble compositions of triphenylethylene antiestrogens." This patent describes aqueous compositions of nonsteroidal triphenylethylene antiestrogens for pharmaceutical use. The compositions include a solubility-enhancing agent, which is a pharmaceutically acceptable mono- or dicarboxylic acid with 1-5 carbon atoms. The carbon chain may also contain hydroxyl, oxo, or halogen substituents, or a corresponding anion, or methanesulfonic acid. The patent emphasizes the importance of these compositions in enhancing the solubility of triphenylethylene antiestrogens, optionally including an organic water-miscible co-solvent such as polyethylene glycol (PEG), propylene glycol, ethanol, or isopropanol.

Career Highlights

Gunilla Örn is associated with Orion Corporation, a prominent company in the pharmaceutical industry. Her work at Orion has allowed her to focus on innovative solutions that address critical needs in drug formulation and delivery.

Collaborations

Gunilla has collaborated with esteemed colleagues, including Kaija Af Ursin and Jukka Salmia. These collaborations have contributed to the advancement of her research and the successful development of her patented compositions.

Conclusion

Gunilla Örn's contributions to the field of pharmaceuticals, particularly through her innovative patent, highlight her role as a key inventor in the industry. Her work continues to influence the development of effective pharmaceutical solutions.